Author

Richard N. Fedorak 1

1 University of Alberta

ADALIMUMAB VERSUS INFLIXIMAB FOR THE TREATMENT OF MODERATE TO SEVERE ULCERATIVE COLITIS IN ADULT PATIENTS WITH NO PRIOR ANTI-TNF EXPERIENCE: AN INDIRECT COMPARISON META-ANALYSIS

Kristian Thorlund, Eric Druyts, Edward Mills, John K. Marshall, Richard N. Fedorak

ALTERATIONS OF FECAL MICROBIOTA AND METABOLIC LANDSCAPE IN RESPONSE TO ORAL OR INTRAVENOUS IRON REPLACEMENT THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Thomas J Lee, Annemarie Schmidt, Ilias Lagkouvardos, Thomas Clavel, Alesia Walter, Marianna Lucio, Kirill Smirnov, Philippe Schmitt-Kopplin, Richard N. Fedorak, Dirk Haller

IN IBD OUTPATIENTS KNOWLEDGE OF FECAL CALPROTECTIN AND INFLIXIMAB TROUGH LEVELS SIGNIFICANTLY ALTERS CLINICAL DECISION MAKING

Vivian Huang, Connie Prosser, Carol Shalapay, Neil Dhami, Darryl Fedorak, Haili Wang, Karen Kroeker, Richard N. Fedorak

THE MAJORITY OF PATIENTS ARE NOT AWARE OF INFLAMMATORY BOWEL DISEASE MEDICATION SIDE EFFECTS

Shakir Ali M Bakkari, Karen Kroeker, Richard N. Fedorak

Item 1 - 4 / 5
1